Projects per year
- 1 - 50 out of 185 results
Search results
-
Completed
Evolution of Anti-Filovirus B Cell Responses and Mechanisms of Protection
5/18/21 → 5/17/22
Project: Other project
-
-
-
-
Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection
7/13/20 → 11/15/21
Project: Other project
-
Intrinsically-Enhanced Ebola Virus Like Particles for Increased Potency and Immune Memory
6/1/20 → 11/15/21
Project: Other project
-
-
-
-
-
Authentic Live Virus Assay (up to 50 samples tested); Lilly #1
4/16/20 → 9/1/21
Project: Other project
-
Authentic Live Virus Assay (up to 50 samples tested); Lilly #1
4/16/20 → 9/1/21
Project: Other project
-
Authentic Live Virus Assay (up to 50 samples tested); Lilly #1
4/16/20 → 9/1/21
Project: Other project
-
Authentic Live Virus Assay (up to 50 samples tested); Lilly #1
4/16/20 → 9/1/21
Project: Other project
-
Authentic Live Virus Assay (up to 50 samples tested); Lilly #1
4/16/20 → 9/1/21
Project: Other project
-
Authentic Live Virus Assay (up to 50 samples tested); Lilly #1
4/16/20 → 9/1/21
Project: Other project
-
Harvest of Lassa GP-Specific PBMCs After Vaccination with EBS-LASV Vaccine
3/16/20 → 6/11/20
Project: Other project
-
Harvest of Lassa GP-Specific PBMCs After Vaccination with EBS-LASV Vaccine
3/16/20 → 6/11/20
Project: Other project
-
Harvest of Lassa GP-Specific PBMCs After Vaccination with EBS-LASV Vaccine
3/16/20 → 6/11/20
Project: Other project
-
Harvest of Lassa GP-Specific PBMCs After Vaccination with EBS-LASV Vaccine
3/16/20 → 6/11/20
Project: Other project
-
Glycoprotein Immunoassay to Measure Protective Response to Lassa Vaccine
3/1/20 → 2/28/21
Project: Other project
-
Glycoprotein Immunoassay to Measure Protective Response to Lassa Vaccine
3/1/20 → 2/28/21
Project: Other project
-
Study 3, AGM vaccine dose-down study (research-grade) for "A Subunit Vaccine (HeV-sG) to Protect Against Nipah and Hendra Disease"
11/1/19 → 2/28/21
Project: Other project
-
Study 3, AGM vaccine dose-down study (research-grade) for "A Subunit Vaccine (HeV-sG) to Protect Against Nipah and Hendra Disease"
11/1/19 → 2/28/21
Project: Other project
-
Study 3, AGM vaccine dose-down study (research-grade) for "A Subunit Vaccine (HeV-sG) to Protect Against Nipah and Hendra Disease"
11/1/19 → 2/28/21
Project: Other project
-
Monoclonal Antibodies Targeting Novel Sites of Vulnerability in Marburg virus Glycoprotein
7/12/19 → 6/30/21
Project: Other project
-
Monoclonal Antibodies Targeting Novel Sites of Vulnerability in Marburg virus Glycoprotein
7/12/19 → 6/30/21
Project: Other project
-
-
-
Consortium for Immunotherapeutics against Emerging Viral Threats
5/1/19 → 4/30/21
Project: Other project
-
Consortium for Immunotherapeutics against Emerging Viral Threats
5/1/19 → 4/30/22
Project: Other project
-
A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera
International AIDS Vaccine Initiative
3/27/19 → 8/31/21
Project: Other project
-
A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera
3/27/19 → 8/31/21
Project: Other project
-
A Vaccine for Prevention of Lassa Fever Based on a Live Vesicular Stomatitis Virus-Lassa Virus Chimera
International AIDS Vaccine Initiative
3/27/19 → 8/31/21
Project: Other project
-
-
-
-
-
-
-
-
Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies
12/24/18 → 11/30/21
Project: Other project
-
Immunoprophylaxis for Marburg Virus With Long-Acting Human Monoclonal Antibodies
10/9/18 → 6/30/19
Project: Other project
-
Generation of a safe yet fully replication-competent filovirus
7/1/18 → 6/30/19
Project: Other project
-
Advanced Development of Multivalent Vaccine Candidates for Filovirus and Lassa Fever
4/1/18 → 6/30/19
Project: Other project